Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests

International Journal of Cancer

Volumn 127, Issue 7, 2010, Pages 1643-1649

  Brenner, Hermann ^a   Haug, Ulrike ^a   Hundt, Sabrina ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Colorectal cancer; Early detection; Fecal occult blood tests; Immunochromatographical; Screening

Indexed keywords

HEMOGLOBIN; GUAIAC;

ADULT; AGED; ARTICLE; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; INTESTINE PREPARATION; KAPPA STATISTICS; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; OCCULT BLOOD TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TEST RETEST RELIABILITY; VALIDATION PROCESS; ADENOMA; BLOOD; COLON POLYP; COLORECTAL TUMOR; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; INTESTINE POLYP; MIDDLE AGED; NEOPLASM; REPRODUCIBILITY;

ADENOMA; AGED; COLONIC POLYPS; COLORECTAL NEOPLASMS; FEMALE; GUAIAC; HUMANS; IMMUNOLOGIC TESTS; INTESTINAL POLYPS; MALE; MIDDLE AGED; NEOPLASMS; OCCULT BLOOD; REPRODUCIBILITY OF RESULTS;

EID: 76949107522     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25154     Document Type: Article

References (20)

1. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, Dash C, Giardiello FM, Glick S, Levin TR, Pickhardt P, Rex DK, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Color\ectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95.
2. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the fecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007;CD001216.
3. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, PaulyMP, Shlager L, Palitz AM, ZhaoWK, Schwartz JS, Ransohoff DF, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007;99:1462-70.
4. Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsène D, Boutreux S, Tichet J, Launoy G. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007;56:210-14.
5. Dancourt V, Lejeune C, Lepage C, Gailliard MC, Meny B, Faivre J. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer 2008;44:2254-8.
6. van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90.
7. Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 2009;150:162-9.
8. Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, van der Togt AC, Kuipers EJ, Habbema JD, van Leerdam ME. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009;100:1103-10.
9. Guittet L, Bouvier V, Mariotte N, Vallee J-P, Levillain R, Tichet J, Launoy G. Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples. Int J Cancer 2009;125:1127-33.
10. Tannous B, Lee-Lewandrowski E, Sharples C, Brugge W, Bigatello L, Thompson T, Benzer T, Lewandrowski K. Comparison of conventional guaiac to four immunochemical methods for fecal occult blood testing: implications for clinical practice in hospital and outpatient settings. Clin Chim Acta 2009;400:120-2.
11. http://www.r-biopharm.com/product-site.php?product-id=39&, Accessed October 26, 2009.
12. Haug U, Brenner H. New stool tests for colorectal cancer screening. A systematic review focusing on performance characteristics and practicalness. Int J Cancer 2005;117:169-76.
13. Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE. Noninvasive testing for colorectal cancer: a review. Am J Gastroentrol 2005;100:1393-403.
14. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005;129:422-8.
15. Wong WM, Lam SK, Cheung KL, Tong TS, Rozen P, Young GP, Chu KW, Ho J, Law WL, Tung HM, Choi HK, Lee YM. Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population. Cancer 2003;97:2420-4.
16. Launoy GD, Bertrand HJ, Berchi C, Talbourdet VY, Guizard AV, Bouvier VM, Caces ER. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer 2005;115:493-6. (Pubitemid 40663756)
17. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Leshno M, Niv Y. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007;146:244-55.
18. Rozen P, Levi Z, Hazazi R, Waked A, Vilkin A, Maoz E, Birkenfeld S, Leshno M, Niv Y. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed. Aliment Pharmacol Ther 2009;29:906-17.
19. Guittet L, Bouvier V, Mariotte N, Vallee JP, Levillain R, Tichet J, Launoy G. Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location. Br J Cancer 2009;100:1230-5.
20. van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006;101:343-50. (Pubitemid 43381678)